32
A.B. Patil, B.M. Bhanage / Journal of Molecular Catalysis A: Chemical 379 (2013) 30–37
injector port temperature 250 ◦C; detector temperature 250 ◦C and
injection volume 0.6 L.
2H), 6.82–6.79 (m, 1H), 3.03 (s, 6H) ppm. 13C NMR (75 MHz,
CDCl3): 150.96, 148.66, 146.88, 139.67, 129.71, 127.79,
123.81, 115.56, 112.88, 111.10, 40.45, 21.04. GC–MS (EI) m/z
(%): 242(1 0 0) [M]+, 212(6.5), 196(19.2), 195(31.1), 152(23.2),
139(3.9), 98(4.7), 76(6.1), 63(4.4), 39(5.1). HRMS (ESI): m/z
calcd. for C14H15O2N2[M + H]+ = 243.11162, found 243.11280.
2.6. Spectral data of selected products
2.6.1. Spectral data of 2-phenoxy-1,1ꢀ-biphenyls
(1) 2-phenoxy-1,1ꢀ-biphenyl (Table 2, entry 1)1H NMR (400 MHz,
CDCl3): 7. 54 (2H, d, J = 10 Hz), 7.45 (1H, m), 7. 34
(2H, d, J = 10 Hz), 7.3–7.18 (5H, m), 7.02 (2H, t), 6.93
(2H, d, J = 10.4 Hz) ppm; GC–MS (EI) m/z (%): 246(100)
[M]+, 245(29.2), 231(11.8), 229(21.8), 228(12.1), 227(14.1),
217(11.4), 202(10.7), 152(37.0), 151(10.5), 115(13.3).
(2) 2ꢀ-phenoxy-[1,1ꢀ-biphenyl]-4-ol (Table 2, entry 2)GC–MS (EI)
m/z (%): 263(18.7), 262(1 0 0) [M]+, 185(5.7), 168(5.4), 157(5.7),
141(6.6), 139(9.3), 115(12.5), 89(5.7), 77(6.7), 45(13.4),
44(11.6).
3. Results and discussion
3.1. Preparation and characterization PdNPs
We initiated our investigation aiming at the synthesis of pal-
ladium nanoplates using the concept of solar energy. The seeds,
crystallinity and the growth rates of different crystallographic
facets are important in determining the shape of resultant nano-
evolution is observed during the growth mechanism: in the initial
state the nanoplates have a circular cross section obtained by the
combination of atoms; then it will evolve into hexagonal and then
triangular shapes [25–27].
(3) 4ꢀ-methyl-2-phenoxy-1,1ꢀ-biphenyl (Table 2, entry 3)1H NMR
(2H, d, J = 10.8 Hz), 7.04–6.92 (4H, m), 2.34 (3H, s) ppm; GC–MS
(EI) m/z (%): 260(1 0 0) [M]+, 245(24.5), 244(7.5), 243(10.8),
217(8.7), 183(8.1), 168(9.8), 165(24.5), 152(21.7), 139(5.1),
115(7.9), 77(6.1).
(4) 4ꢀ-nitro-2-phenoxy-1,1ꢀ-biphenyl (Table 2, entry 4)1H NMR
(400 MHz, CDCl3): 8.2 (2H, d, J = 11.6 Hz), 7.7 (2H, d, J = 11.6 Hz),
(2H, d, J = 10.4 Hz) ppm; GC–MS (EI) m/z (%): 291(1 0 0) [M]+,
245(9.1), 244(20.1), 228(10.0), 226(10.1), 218(11.7),215(17.6),
202(13.1), 168(8.9), 152(8.8), 151(10.0), 139(13.0) 77(11.9),
51(8.6).
Cuboctahedrons and multiple twinned particles (MTPs) are the
thermodynamically favourable shapes of Pd nanoparticles. At high
reduction rate the final product will take the thermodynamically
favoured shapes. When the reduction rate retarded, the nuclea-
tion as well as growth will be deviating into kinetic control and
thermodynamic ones. In previous studies, it was found that at ele-
(EI) m/z (%): 260(1 0 0) [M]+, 245(6.7), 182(14.9), 181(25.3),
165(57.8), 151(20.9), 149(33.4), 115(11.5), 91(61.4), 77(8.9),
51(8.0).
vated temperature PdCl4 was added to EG, the rapid reduction
2−
of PdCl42− takes place with EG and produced 10% MTPs and 90% Pd
cubooctahedra of 8–10 nm in size [28].
As development of nanoplates is favourable at slow reduction
process, the selective synthesis of Pd nanoplates has been attained
by careful control of the reduction kinetics, mainly at the seeding
stage. In earlier work, to achieve controlled synthesis of triangu-
lar and hexagonal nanoplates two different approaches have been
reported to retard the reduction rate. In first approach, the reduc-
tion rate was substantially reduced through the introduction of
etchants like Fe(III) species, which competed with the polyol reduc-
tion and altered the reduction kinetics helps to synthesis triangular
or hexagonal nanoplates [29]. In the second approach, a mild reduc-
ing agent like PVP can be used to slow down the reduction [30]. The
mild reducing power of such compound is anticipated for kineti-
cally controlled synthesis of Pd nanoplates.
(6) 2-methoxy-2ꢀ-phenoxy-1,1ꢀ-biphenyl (Table 2, entry 6)1H NMR
(400 MHz, CDCl3): 7. 36 (1H, dd, J = 5.2 Hz), 7.3–7.2 (5H, m),
s) ppm; GC–MS (EI) m/z (%): 276(1 0 0) [M]+, 215(7.5), 183(7.5),
91(20.5), 77(5.5).
(7) 2ꢀ-phenoxy-[1,1ꢀ-biphenyl]-2-ol(Table 2, entry 7)GC–MS (EI)
m/z (%): 262(1 0 0) [M]+, 170(11.9), 169(95.0), 168(79.1),
141(20.3), 139(24.4), 115(18.5), 77(8.4), 51(8.2), 39(7.8).
(8) 2ꢀ-phenoxy-[1,1ꢀ-biphenyl]-2-amine (Table 2, entry 8)GC–MS
(EI) m/z (%): 261(41.6) [M]+, 169(10.0), 168(69.2), 167(100),
166(10.6), 139(8.2), 115(5.6), 89(9.1), 58(5.5), 45(24.0),
44(18.0), 43(7.6).
On the basis of the above discussion, herein concentrated
solar energy protocol has been used for hexagonal and triangu-
lar nanoplates synthesis using a polyol synthesis protocol with
PVP (MW = 40,000) as a stabilizer cum mild reductant. In case
of Pd nanoparticle synthesis higher driving force is required
for the reduction of ionic palladium species. Concentrated solar
energy has combined effect of the thermal and radiational energy
help to reduce ionic palladium to metallic palladium. Though,
concentrated solar energy executes necessity of the ionic palla-
dium reduction, the high intensity sunlight may create obstacle
for nanoplate synthesis as it required slow reduction kinetics.
Hence, essential energy requirement for nanoplates preparation
was achieved by moving the ‘Fresnel lens’ towards the reactor
(round bottom flask) which allows optimum sunlight concentra-
tion of ionic palladium but also it could be used for the selective
nanoplate’s formation too. Also, low molecular weight PVP act as a
mild reductant to slow down the reduction process along with its
capping effect [29,30]. In general, glycols can serve as the reduc-
tant source for the PdNPs synthesis [29,31]. In aqueous medium
2.6.2. Spectral data of N,N-dimethyl-[1,1ꢀ-biphenyl] derivatives
(9) N,N-4ꢀ-trimethyl-[1,1ꢀ-biphenyl]-3-amine (Table 3, entry
1)1H NMR (400 MHz, CDCl3): 7.49 (d, J = 8.1 Hz, 2H), 7.23
(t, J = 7.3 Hz, 1H), 7.22 (d, J = 8.1 Hz, 2H), 6.94–6.91 (m, 2H),
6.73–6.71 (m, 1H), 2.99 (s, 6H), 2.38 (s, 3H) ppm. 13C NMR
(75 MHz, CDCl3): 150.90, 142.13, 139.33, 136.70, 129.30,
129.25, 127.10, 115.70, 111.40, 40.64, 21.04. GC–MS (EI) m/z
(%): 211(1 0 0) [M]+, 195(8.1), 168(9.2), 165(11.4), 152(13.6),
105(18.2), 82(5.1), 63(2.7), 39(4.6). HRMS (ESI): m/z calcd. for
C15H18N[M + H]+ = 212.14338, found 212.14261.
(10) 2ꢀ-methoxy-N,N-dimethyl-[1,1ꢀ-biphenyl]-3-amine (Table 3,
entry 2)1H NMR (300 MHz, CDCl3): 7.45–7.16 (m, 3H),
7.02–6.83 (m, 4H), 6.71 (d, J = 8.1 Hz, 1H), 3.77 (s, 3H), 2.94
(s, 6H) ppm. GC–MS (EI) m/z (%): 227(1 0 0) [M]+, 210(26.3),
196(13.3), 183(9.2), 181(9.0), 168(14.2), 152(5.6), 139(9.6),
113(8.1), 108(14.1), 98(10.8), 91(5.9), 78(5.8), 63(3.6), 39(4.8).
(11) N,N-dimethyl-4ꢀ-nitro-[1,1ꢀ-biphenyl]-3-amine (Table 3,
entry 3)1H NMR (300 MHz, CDCl3): 8.26 (d, J = 8.7 Hz, 2H),
7.72 (d, J = 8.7 Hz, 2H), 7.35 (t, J = 7.9 Hz, 2H), 6.95–6.88 (m,